Bulletin
Investor Alert

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 4:59 p.m.

/zigman2/quotes/203973516/composite

$

401.37

Change

0.00 0.00%

Volume

Volume 2,092

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Today's close

$ 396.34

$ 401.37

Change

+5.03 +1.27%

Day low

Day high

$395.58

$408.57

Open

52 week low

52 week high

$228.67

$444.83

Open

Kim Kelderman

Kim Kelderman is General Manager of GeneOhm Sciences Canada, Inc. Prior to joining GeneOhm Sciences Canada, he was Chief Operating Officer and a Director of Oculus Innovative Sciences, Inc. Mr. Kelderman was President and General Manager of Jomed, Inc. (formerly EndoSonics Corp.). Previously, he held senior management positions at Intravascular Research Ltd., Jomed GmbH, EndoSonics Europe, and Medtronic Vascular, Inc. Mr. Kelderman received a degree in Mechanical Engineering from the Heerlen Polytechnic and Eindhoven University.

Transactions

Date Shares Transaction Value
05/01/2021 856   Derivative/Non-derivative trans. at $427.49 per share. 365,932
05/01/2021 1,667   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2021 823   Disposition at $388.45 per share. 319,695
05/01/2020 821   Derivative/Non-derivative trans. at $227.54 per share. 186,811
05/01/2020 1,666   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2019 844   Derivative/Non-derivative trans. at $202.13 per share. 170,598
05/01/2019 1,667   Derivative/Non-derivative trans. at $202.13 per share. 336,950

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Senior Director-Investor Relations
Mr. Struan Robertson
Vice President–Human Resources
Mr. Robert V. Baumgartner
Chairman
Dr. Rupert J. Vessey
Independent Director
Ms. Julie L. Bushman
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna H. Seth
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.